CDC Group unveils investment committee appointments
CDC Group, the UK’s publicly owned impact investor, has made two hires to its investment committee as it prepares to expand its interests in the sector.
Anne Glover, CEO of Amadeus Capital Partners and Non-Executive Director of the Court of the Bank of England; and Nikunj Jinsi, former Global Head of Venture Capital at the International Finance Corporation, will both join. They will sit on a newly formed Venture Capital Investment Committee at CDC and advise on venture capital funds and co-investment proposals.
CDC’s new venture capital strategy focuses on partnerships with VC funds across key technology hubs in Africa and south Asia. It is supplemented by its Venture Scale-up co-invest programme designed to support CDC-backed VC funds to coinvest in early-stage companies that leverage technology and innovative business models to achieve transformational impact at scale.
Glover is CEO and Co-founder of Amadeus Capital Partners, a global technology investor. A former Chair of the BVCA and of Invest Europe, she is a member of the London Business School’s Private Equity Institute Advisory Board. She is also a Non-Executive Director of the Court of the Bank of England and became a member of the Investment Committee of Yale Corporation in 2019.
Jinsi has over 20 years of VC investment experience in developing markets. He has held board positions in several leading technology companies in emerging markets and spent 16 years at the International Finance Corporation, where he built the venture capital practice as its Global Head, and led over 80 transactions. Jinsi is currently a Senior Advisor to several European institutions.
